MedPath

MEPROBAMATE

Meprobamate Tablets USP Rx Only

Approved
Approval ID

a0891a32-105b-48bc-a246-5e179d2e7fa1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2023

Manufacturers
FDA

Alembic Pharmaceuticals Limited

DUNS: 650574663

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MEPROBAMATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code46708-019
Application NumberANDA090122
Product Classification
M
Marketing Category
C73584
G
Generic Name
MEPROBAMATE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 10, 2023
FDA Product Classification

INGREDIENTS (6)

MEPROBAMATEActive
Quantity: 200 mg in 1 1
Code: 9I7LNY769Q
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MEPROBAMATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code46708-020
Application NumberANDA090122
Product Classification
M
Marketing Category
C73584
G
Generic Name
MEPROBAMATE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 10, 2023
FDA Product Classification

INGREDIENTS (6)

MEPROBAMATEActive
Quantity: 400 mg in 1 1
Code: 9I7LNY769Q
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEPROBAMATE - FDA Drug Approval Details